Select a metric from the list below to chart it
Metric | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | LTM |
|---|---|---|---|---|---|---|
Total Revenues | 483.4 | 994.1 | 1,451.1 | 2,793.1 | 2,817.1 | 3,032.1 |
Total Revenues % Chg. | — | 105.7% | 46.0% | 92.5% | 0.9% | 4.3% |
Cost of Goods Sold, Total | 53.8 | 241.3 | 555.6 | 988.1 | 1,203.1 | 1,102.0 |
Gross Profit | 429.6 | 752.8 | 895.5 | 1,805.0 | 1,614.0 | 1,930.2 |
Selling General & Admin Expenses, Total | 181.7 | 509.7 | 685.9 | 1,271.9 | 1,072.9 | 952.9 |
R&D Expenses | 16.3 | 45.0 | 180.7 | 366.4 | 507.6 | 559.8 |
Other Operating Expenses, Total | 197.9 | 554.7 | 866.6 | 1,638.3 | 1,580.5 | 1,512.7 |
Operating Income | 231.7 | 198.2 | 28.9 | 166.7 | 33.5 | 417.5 |
Interest Expense, Total | -62.1 | -74.0 | -77.9 | -84.9 | -171.9 | -254.5 |
Interest And Investment Income | 2.1 | — | — | — | — | 32.9 |
Net Interest Expenses | -60.0 | -74.0 | -77.9 | -84.9 | -171.9 | -221.6 |
Currency Exchange Gains (Loss) | — | — | -1.2 | 1.5 | 0.2 | -0.4 |
Other Non Operating Income (Expenses) | — | 5.8 | 5.4 | -2.1 | 14.3 | 14.3 |
EBT, Excl. Unusual Items | 171.7 | 130.0 | -44.7 | 81.2 | -123.9 | 209.8 |
Merger & Related Restructuring Charges | — | -3.8 | -7.9 | -16.9 | -28.3 | -8.2 |
Gain (Loss) On Sale Of Investments | — | — | — | — | — | 2.3 |
Asset Writedown | — | — | — | — | -53.0 | -53.0 |
Other Unusual Items | -411.9 | — | -83.1 | -18.0 | — | -15.4 |
EBT, Incl. Unusual Items | -240.3 | 126.2 | -135.7 | 46.3 | -205.2 | 135.5 |
Income Tax Expense | 19.7 | 7.2 | -9.8 | 11.0 | -12.2 | 30.5 |
Earnings From Continuing Operations | -260.0 | 119.0 | -125.9 | 35.3 | -192.9 | 105.0 |
Minority Interest | — | — | 0.7 | 0.1 | 0.2 | — |
Net Income | -260.0 | 119.0 | -125.2 | 35.4 | -192.7 | 105.0 |
Preferred Dividend and Other Adjustments | — | 42.7 | — | 3.7 | — | 1.0 |
Net Income to Common Incl Extra Items | -260.0 | 76.4 | -125.2 | 31.7 | -192.7 | 104.0 |
Net Income to Common Excl. Extra Items | -260.0 | 76.4 | -125.2 | 31.7 | -192.7 | 104.0 |
Total Shares Outstanding | 189.5 | 220.2 | 226.4 | 375.1 | 373.9 | 335.8 |
Weighted Avg. Shares Outstanding | 189.5 | 210.9 | 214.9 | 324.8 | 371.6 | 360.5 |
Weighted Avg. Shares Outstanding Dil | 189.5 | 212.4 | 214.9 | 342.8 | 371.6 | 369.0 |
EPS | -1.4 | 0.4 | -0.6 | 0.1 | -0.5 | 0.3 |
EPS Diluted | -1.4 | 0.4 | -0.6 | 0.1 | -0.5 | 0.3 |
EBITDA | 247.7 | 291.0 | 283.9 | 597.7 | 580.6 | 889.0 |